New note out today on from NDF Research on Patrys, ASX Code PAB, which updates our 19 December 2017 note headlined ‘Cell-penetrating monoclonal antibodies’. You can check it out by clicking here - note the usual disclaimers apply. Below is a video where I discuss what you'll learn in my Patrys update.
0 Comments
|
Stuart RobertsSenior Analyst, NDF Research Archives
May 2018
Categories |